Open AccessSerum VEGFR-3 and survival of advanced gastric cancer patients treated with FOLFOX
Author(s) -
Xuefeng Ni,
Changping Wu,
Jingting Jiang
Publication year - 2010
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v16.i17.2163
Subject(s) - carcinoembryonic antigen , medicine , folfox , folinic acid , oxaliplatin , gastroenterology , hazard ratio , chemotherapy , fluorouracil , cancer , colorectal cancer , oncology , confidence interval
To explore if vascular endothelial growth factor receptor-3 (VEGFR-3) and carcinoembryonic antigen (CEA) can predict overall survival in advanced gastric cancer.